Jeff Yass’s Humacyte Inc Warrant HUMAW Stock Holding History

Jeff Yass’s Portfolio HUMAW Stock Details HUMAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97	Sell	10,059 -34,458	-77%	-$2.24K	﹤0.01%	13274
2026 Q1	$4.07K	Sell	44,517 -30,859	-41%	-$3.53K	﹤0.01%	12993
2025 Q4	$6.41K	Buy	+75,376	New	+$14.4K	﹤0.01%	12083
2025 Q3	–	Sell	-17,591	Closed	-$7.04K	–	13049
2025 Q2	$7.04K	Buy	17,591 +6,831	+63%	+$2.96K	﹤0.01%	12428
2025 Q1	$3.98K	Buy	+10,760	New	+$13.4K	﹤0.01%	12269
2023 Q1	–	Sell	-20,102	Closed	-$7.89K	–	12964
2022 Q4	$7.89K	Buy	+20,102	New	+$17.8K	﹤0.01%	11972

Other funds holding HUMAW

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Jeff Yass's HUMAW Position: Q2 2026 in Review

Jeff Yass reduced its Humacyte Inc Warrant (HUMAW) stake by 77% in Q2 2026, selling an estimated $2.24K and leaving 10,059 shares worth $97. The position accounts for ﹤0.01% of the portfolio, ranked #13274.

Jeff Yass first reported a position in HUMAW in Q4 2022 and has held it in 6 quarters since. The position peaked at $7.89K in Q4 2022. 8 funds tracked by Wall St. Rank hold HUMAW as of Q2 2026.

Jeff Yass held 10,059 shares of Humacyte Inc Warrant worth $97 as of Q2 2026.
Jeff Yass sold 34,458 Humacyte Inc Warrant shares in Q2 2026, an estimated $2.24K.
Humacyte Inc Warrant made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13274 holding.
Jeff Yass first reported a position in Humacyte Inc Warrant in Q4 2022 and has held it in 6 quarters since.
Jeff Yass's Humacyte Inc Warrant position peaked at $7.89K in Q4 2022.
8 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.